Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

ClinicalTrials.gov ID: NCT02232425

Public ClinicalTrials.gov record NCT02232425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation

Study identification

NCT ID
NCT02232425
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ixchelsis Limited
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

  • IX-01 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2014
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Aug 16, 2020

2014 – 2015

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
San Diego Sexual Medicine San Diego California 92120
South Florida Medical Research Inc. Aventura Florida 33180
Center for Marital and Sexual Health of South Florida West Palm Beach Florida 33401
Tulane University School of Medicine New Orleans Louisiana 70112
Cooper Research Institute Camden New Jersey 08103
Manhattan Medical Research New York New York 10016
Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd Pennsylvania 19004
Miriam Hospital / The Men's Health Center Providence Rhode Island 02906

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02232425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02232425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →